OCC Trading, page-1558

Fair enough, mate. I don't think there will be any TO now or in the near future, not until all their products are on the market and big pharma recognize their value. Don’t forget HS locked up OCC pretty tight with their BioH’s Striate deal all but negating any chance of a TO by others at substantial costs.

I 'm afraid OCC is just one of those companies that the market only wakes up to after repeatedly strong earnings reports, quarter after quarter. There are plenty of companies on the ASX winning decent contracts yet the SP languishes. It's the Australian fund managers and brokers (plus the pitiful amount of retail)... devoid of any nuance or foresight. They constantly complain about there being nothing to invest in here, yet balk at any opportunity thrown their way. I used to knew a few advisors here in Brisbane working at different brokerage houses… a bunch of yahoos more interested in drinking and gambling on horses than anything else.